B. Riley Wealth Management’s Zymergen Inc. Common Stock ZY Stock Holding History

B. Riley Wealth Management’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$49K	Buy	+39,500	New	+$66.2K	0.01%	662

Other funds holding ZY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

TVPI

True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DCI

Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSV

Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

B. Riley Wealth Management's ZY Position: Q2 2022 in Review

B. Riley Wealth Management opened a new position in Zymergen Inc. Common Stock (ZY) in Q2 2022: 39,500 shares worth $49K. The stake represents 0.01% of the portfolio and ranks #662 among its holdings.

81 funds tracked by Wall St. Rank hold ZY as of Q2 2022.

B. Riley Wealth Management held 39,500 shares of Zymergen Inc. Common Stock worth $49K as of Q2 2022.
Zymergen Inc. Common Stock was a new B. Riley Wealth Management position in Q2 2022.
Zymergen Inc. Common Stock made up 0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #662 holding.
81 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.